Global University Venturing

Immonogenomics blood test developer OncoCell, a Harvard Medical School spinout, has increased its total funding to $30m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Laser project technology company Casiris Technology lured Cash Capital and Cas Star to the table for its series D-plus round.

Woodford Investment Management is reportedly poised for another beating as its portfolio company BenevolentAI seeks funding from Temasek at half of its previous $2bn valuation.

Max Planck Foundation joined the EIF and AWS as a limited partner in university-focused drug discovery fund Khan Technology Transfer Fund I.

Osage University Partners has celebrated an exit as migraine treatment developer Satsuma Pharmaceuticals listed on the Nasdaq Global Market following an $82.5m offering.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.

University of Arkansas Technology Ventures pushed forth with 47 invention disclosures in 2018-19, a 52% year-on-year rise.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis and Novo helped provide $40m for the EPFL spinout that supported its acquisition of joint venture Kanyos Bio.